Company intelligence
ARENSIA Exploratory Medicine GmbH
A German operator of professional research clinics specialized in performing early-phase patient trials.
About ARENSIA Exploratory Medicine GmbH
ARENSIA is the world’s only privately owned and operated early-phase patient clinic network, purpose-built to deliver proof-of-concept clinical trials in patients up to 50% faster and at substantially lower cost than traditional research models. Our fully integrated model—combining owned clinics, dedicated research physicians, and access to large, diverse patient populations across oncology, chronic, and acute diseases—accelerates patient recruitment, trial execution, and decision-making, enabling sponsors to achieve critical development milestones faster than conventional approaches.
Verified activity
Signals from ARENSIA Exploratory Medicine GmbH
2 published signals
Research & Knowledge
ARENSIA Exploratory Medicine GmbH achieved the milestone of First Patient Dosed worldwide among 10 global sites in a complex multinational, multicenter Phase I/II oncology study in colorectal cancer.
Reported by ARENSIA Exploratory Medicine GmbH
Presence & Recognition
ARENSIA Exploratory Medicine GmbH wrapped up ESC Congress 2026 in Munich, energized by new projects and clinical trials.
Reported by ARENSIA Exploratory Medicine GmbH